Accelerate Diagnostics
AXDX
#11223
Rank
โ‚น83.17 M
Marketcap
โ‚น3.29
Share price
0.00%
Change (1 day)
-96.50%
Change (1 year)

Revenue for Accelerate Diagnostics (AXDX)

Revenue in 2024 (TTM): โ‚น0.98 Billion

According to Accelerate Diagnostics's latest financial reports the company's current revenue (TTM ) is โ‚น1.13 Billion. a decrease over the revenue in the year 2023 that were of โ‚น1.00 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Accelerate Diagnostics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น1.00 B-0.04%
2023 โ‚น1.00 B-4.86%
2022 โ‚น1.05 B20.33%
2021 โ‚น0.87 B7.4%
2020 โ‚น0.81 B23.15%
2019 โ‚น0.66 B67.22%
2018 โ‚น0.39 B48.69%
2017 โ‚น0.26 B1495.04%
2016 โ‚น16.71 M71.12%
2015 โ‚น9.76 M26.34%
2014 โ‚น7.73 M158.39%
2013 โ‚น2.99 M
2011 โ‚น29.17 M-78%
2010 โ‚น0.13 B326.47%
2009 โ‚น31.1 M-31.28%
2008 โ‚น45.25 M378.78%
2007 โ‚น9.45 M0.58%
2006 โ‚น9.39 M-45.22%
2005 โ‚น17.15 M-16163.56%
2004 -โ‚น0.11 Million-100.45%
2003 โ‚น23.55 M-36.03%
2002 โ‚น36.81 M46.62%
2001 โ‚น25.11 M-54.73%
2000 โ‚น55.47 M-48.25%
1999 โ‚น0.10 B-45.51%
1998 โ‚น0.19 B-14.21%
1997 โ‚น0.22 B177.32%
1996 โ‚น82.68 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น4.482 T 396,001.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚น2.015 T 178,050.11%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚น324.76 B 28,601.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
โ‚น338.51 B 29,816.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
โ‚น15.71 B 1,288.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
โ‚น250.46 B 22,034.55%๐Ÿ‡บ๐Ÿ‡ธ USA